-
公开(公告)号:EP2560971B1
公开(公告)日:2014-04-09
申请号:EP11715847.7
申请日:2011-04-14
申请人: Abbvie Inc.
IPC分类号: C07D471/04 , A61K31/513 , A61K31/444 , A61P35/00
CPC分类号: C07D471/04
-
公开(公告)号:EP2560971A1
公开(公告)日:2013-02-27
申请号:EP11715847.7
申请日:2011-04-14
申请人: Abbvie Inc.
IPC分类号: C07D471/04 , A61K31/513 , A61K31/444 , A61P35/00
CPC分类号: C07D471/04
摘要: The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, Formula (I) wherein R
1a , R
1b , R
1c , X, and Y are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as Cdc7 and methods of treating diseases such as cancer.
-